Novel Mouse Model of ChronicPseudomonas aeruginosaLung Infection Mimicking Cystic Fibrosis
Open Access
- 1 April 2005
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 73 (4), 2504-2514
- https://doi.org/10.1128/iai.73.4.2504-2514.2005
Abstract
Pseudomonas aeruginosa causes a chronic infection in the lungs of cystic fibrosis (CF) patients by establishing an alginate-containing biofilm. The infection has been studied in several animal models; however, most of the models required artificial embedding of the bacteria. We present here a new pulmonary mouse model without artificial embedding. The model is based on a stable mucoid CF sputum isolate (NH57388A) with hyperproduction of alginate due to a deletion in mucA and functional N-acylhomoserine lactone (AHL)-based quorum-sensing systems. Chronic lung infection could be established in both CF mice (CftrtmlUnc−/−) and BALB/c mice, as reflected by the detection of a high number of P. aeruginosa organisms in the lung homogenates at 7 days postinfection and alginate biofilms, surrounded by polymorphonuclear leukocytes in the alveoli. In comparison, both an AHL-producing nonmucoid revertant (NH57388C) from the mucoid isolate (NH57388A) and a nonmucoid isolate (NH57388B) deficient in AHL were almost cleared from the lungs of the mice. This model, in which P. aeruginosa is protected against the defense system of the lung by alginate, is similar to the clinical situation. Therefore, the mouse model provides an improved method for evaluating the interaction between mucoid P. aeruginosa, the host, and antibacterial therapy.Keywords
This publication has 105 references indexed in Scilit:
- Pseudomonas aeruginosa alginate is refractory to Th1 immune response and impedes host immune clearance in a mouse model of acute lung infectionJournal of Medical Microbiology, 2003
- Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patientsJCI Insight, 2002
- Early immune response in susceptible and resistant mice strains with chronic Pseudomonas aeruginosa lung infection determines the type of T‐helper cell responseAPMIS, 1999
- Antibiotic Therapy for Chronic Infection of Pseudomonas in the LungAnnual Review of Medicine, 1993
- Mucosal immunity to Pseudomonas aemginosa alginate in cystic fibrosisAPMIS, 1992
- Opsonophagocytic Killing Antibody toPseudomonas aeruginosaMucoid Exopolysaccharide in Older Noncolonized Patients with Cystic FibrosisThe New England Journal of Medicine, 1987
- PREVALENCE OF MUCOID STRAINS OF PSEUDOMONAS AERUGINOSA IN BACTERIOLOGICAL SPECIMENS FROM PATIENTS WITH CYSTIC FIBROSIS AND PATIENTS WITH OTHER DISEASESActa Pathologica Microbiologica Scandinavica Section B Microbiology, 1975
- A mutation suppressing streptomycin dependence: I. An effect on ribosome functionJournal of Molecular Biology, 1967
- DNA replication and the division cycle in Escherichia coliJournal of Molecular Biology, 1967
- A Polysaccharide resembling Alginic Acid from a Pseudomonas Micro-organismNature, 1964